Gabriel Leprivier

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Liquid-liquid phase-separated tau colocalizes with and stabilizes Aβ oligomers.

Liquid-liquid phase-separated tau colocalizes with and stabilizes Aβ oligomers.

Journal: Communications chemistry
Published: April 13, 2026

High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma.

High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma.

Journal: The Journal of clinical investigation
Published: October 01, 2024

The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma.

The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma.

Journal: Cell death discovery
Published: July 29, 2024

A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases.

A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases.

Journal: Journal of neuro-oncology
Published: January 18, 2024

The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.

The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.

Journal: Journal of neuro-oncology
Published: October 06, 2023

Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma.

Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma.

Journal: Acta neuropathologica
Published: May 11, 2023

The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation.

The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation.

Journal: Cell death & disease
Published: April 06, 2023

mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism.

mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism.

Journal: Nature communications
Published: February 05, 2023

Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.

Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.

Journal: Journal for immunotherapy of cancer
Published: December 13, 2022

Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation.

Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation.

Journal: Cell death and differentiation
Published: April 21, 2022

EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma.

EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma.

Journal: Cell death discovery
Published: January 19, 2022

Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation.

Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation.

Journal: Cell death discovery
Published: November 30, 2021
Showing 1-12 of 40

Last Updated: 09/26/2026